Bromide

Bromide

SCHEMBL5140489

Br.Fc1ncccc1CNCc1ccc(CN(Cc2nc3ccccc3[nH]2)C2CCCc3cccnc32)cc1

nearest known ligand 0.78

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ACHEADRA1AADRA1BADRA1DADRA2AADRA2BADRA2CADRB1ADRB2ADRB3APH1AAPH1BCHRM2CHRM3EZH2GRIN2AHTR1AHTR1BHTR1DHTR1FHTR3ANCSTNP2RY12PSEN1PSEN2PSENENSIGMAR1SLC6A2SLC6A3SLC6A4

The experimentally established mechanism targets of Bromide. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 6)

geneUniProtsupporting neighboursconfidence
CHRM2 known ✓ P08172 1/20 0.60
CXCR4 P61073 20/20 0.78
CYP2D6 P10635 1/20 0.60
DRD2 P14416 1/20 0.60
OPRM1 P35372 1/20 0.60
KCNH2 Q12809 1/20 0.60

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4068091 0.99 CXCR4 (0.79) CXCR4CHRM2CYP2D6DRD2OPRM1
Bromide SCHEMBL5140422 0.94 CXCR4 (0.77) CXCR4CHRM2CYP2D6DRD2OPRM1
SCHEMBL4068265 0.94 CXCR4 (0.78) CXCR4CHRM2CYP2D6DRD2OPRM1
Bromide SCHEMBL5140052 0.92 CXCR4 (0.86) CXCR4CHRM2CYP2D6DRD2OPRM1
Bromide SCHEMBL5140353 0.92 CXCR4 (0.86) CXCR4CHRM2CYP2D6DRD2OPRM1
Bromide SCHEMBL5139905 0.91 CXCR4 (0.77) CXCR4CHRM2CYP2D6DRD2OPRM1
Bromide SCHEMBL5141004 0.91 CXCR4 (0.77) CXCR4CHRM2CYP2D6DRD2OPRM1
SCHEMBL4069793 0.91 CXCR4 (0.87) CXCR4CHRM2CYP2D6DRD2OPRM1
SCHEMBL4063485 0.91 CXCR4 (0.87) CXCR4CHRM2CYP2D6DRD2OPRM1
SCHEMBL4064498 0.91 CXCR4 (0.78) CXCR4CHRM2CYP2D6DRD2OPRM1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7396840-B2 Chemokine receptor binding heterocyclic compounds GENZYME CORPORATION (US) 2008-07-08 US disclosed